|本期目录/Table of Contents|

[1]赵丹彤,闫惠平.自身免疫性肝病抗原抗体研究及临床意义[J].传染病信息,2018,02:97-100.
 ZHAO Dan-tong,YAN Hui-ping*.Research and clinical significance of antigens and antibodies in autoimmune liver disease[J].Infectious Disease Information,2018,02:97-100.
点击复制

自身免疫性肝病抗原抗体研究及临床意义(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2018年02期
页码:
97-100
栏目:
导向与述评
出版日期:
2018-03-20

文章信息/Info

Title:
Research and clinical significance of antigens and antibodies in autoimmune liver disease
作者:
赵丹彤闫惠平
100069,首都医科大学附属北京佑安医院自身免疫 性肝病临床研究中心暨临床检验中心(赵丹彤、闫惠平)
Author(s):
ZHAO Dan-tong YAN Hui-ping*
Clinical Research Center for Autoimmune Liver Disease & Clinical Laboratory Center, Beijing You'an Hospital, Capital Medical University, 100069, China
关键词:
自身免疫性肝炎胆汁性胆管炎硬化性胆管炎自身抗体
Keywords:
autoimmune hepatitis biliary cholangitis sclerosing cholangitis autoantibodies
分类号:
R575
DOI:
10.3969/j.issn.1007-8134.2018.02.001
文献标识码:
A
摘要:
自身免疫性肝病(autoimmune liver disease, AILD)主要包括自身免疫性肝炎、原发性胆汁性胆管炎和原发性 硬化性胆管炎。不同类型的AILD 有不同特征的自身抗体谱,自身抗体不仅具有诊断价值,在发病机制、疾病分型、早期诊 断甚至预后判断方面也有重要作用。本文就AILD 抗原抗体研究进展及临床意义作一综述。
Abstract:
Autoimmune liver disease(AILD) is a group disease including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. Different AILD has its typical autoantibody profile, which not only have diagnostic values but also can be used in pathogenesis, disease subtypes, early diagnosis, efficacy evaluation and prognostic evaluation. The article reviews AILD related antigens, antibodies and their clinical significance.

参考文献/References

[1] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: autoimmune hepatitis[J]. J Hepatol, 2015, 63(4):971-1004.
[2] Chan EK, Damoiseaux J, Carballo OG, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 Cell patterns 2014-2015[J]. Front Immunol, 2015, 6:412.
[3] Healey R, Corless L, Gordins P, et al. Do anti-smooth muscle antibodies predict development of autoimmune hepatitis in patients with normal liver function? - A retrospective cohort review[J]. Autoimmun Rev, 2016, 15(7):668-672.
[4] 韩莹,闫惠平,廖慧钰,等. 抗肝肾微粒体抗体在肝病患者中 的临床意义评价[J] . 中华肝脏病杂志,2017,25(11):852- 857.
[5] Kerkar N, Choudhuri K, Ma Y, et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self crossreactivity in liver kidney microsomal autoantibody type 1-positive liver disease[J]. J Immunol, 2003, 170(3):1481-1489.
[6] Yuksel M, Wang Y, Tai N,et al. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation[J]. Hepatology, 2015, 2(5):1536-1550.
[7] Zachou K, Gampeta S, Gatselis NK, et al. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis[J]. Liver Int, 2015, 35(2):660-672.
[8] 赵丹彤,闫惠平,檀玉芬,等. 抗Ro-52 抗体在自身免疫 性肝病中的检测[J]. 中华微生物学和免疫学杂志,2009, 29(7):656-659.
[9] Zachou K, Gampeta S, Gatselis NK, et al. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis[J]. Liver Int, 2015, 35(2):660-672.
[10] Zhao Y, Zhang Y, Liu YM, et al. Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis[J]. Liver Int, 2011, 31(5):721-729.
[11] Hausdorf G, Roggenbuck D, Feist E, et al. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA- -revival of a disease-activity marker in autoimmune hepatitis[J]. Clin Chim Acta, 2009, 408(1-2):19-24.
[12] 中华医学会肝病学分会,中华医学会消化病学分会,中华医 学会感染病学分会. 自身免疫性肝炎诊断和治疗共识(2015) [J]. 中华肝脏病杂志,2016,24(1):23-35.
[13] Xia Q, Lu F, Yan HP, et al. Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis[J]. J Proteome Res, 2008, 7(5):1963-1970.
[14] Xiang D, Xia Q, Chen D, et al. Detection of D-3-phosphoglycerate dehydrogenase autoantibodies in patients with autoimmune hepatitis: clinical significance evaluation[J]. Hepatol Res, 2011, 41(9):867-876.
[15] 刘燕敏,冯霞,廖慧钰, 等. 3- 磷酸甘油酸脱氢酶抗体 对自身免疫性肝炎诊断意义评价[J]. 北京医学,2013, 35(9):780-783.
[16] 廖慧钰,李艳丽,闫惠平,等. 抗延胡索酸水合酶抗体间接 酶联免疫吸附试验法的建立及其对自身免疫性肝炎的诊断价 值[J]. 中华风湿病学杂志,2014,18(12):819-822.
[17] Zingaretti C, Arigò M, Cardaci A, et al. Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis[J]. Mol Cell Proteomics, 2012, 11(12):1885-1897.
[18] Clemente MG, Antonucci R, Mandato C, et al. Autoantibodies against CYP-2C19: a novel serum marker in pediatric de novo autoimmune hepatitis?[J]. Biomed Res Int, 2017, 2017:3563278.
[19] 闫惠平,张海萍,陈欣欣. 如何认识原发性胆汁性胆管炎自 身抗体的临床意义[J]. 中华肝脏病杂志,2017,25(11):810- 813.
[20] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67(1):145-172.
[21] 中华医学会肝病学分会,中华医学会消化病学分会,中华医 学会感染病学分会. 原发性胆汁性肝硬化(又名原发性胆汁 性胆管炎)诊断和治疗共识(2015)[J]. 中华肝脏病杂志, 2016,24(1):5-13.
[22] 张福奎,贾继东. 老年原发性胆汁性肝硬化的临床特色[J]. 传染病信息,2006,19(3):99-100.
[23] 牛泱平,李川. 抗M2-3E ELISA: 一种新型、高效的PBC 血清 学诊断方法[J]. 国际检验医学杂志,2011,32(6):694-695.
[24] 闫惠平,庄辉,刘燕敏,等. 原发性胆汁性肝硬化患者的免 疫学特点分析[J]. 中华肝脏病杂志,2005,13(1):12-16.
[25] Muratori P, Muratori L. Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis[J]. Clin Res Hepatol Gastroenterol, 2017, 41(4):e47.
[26] Yang F, Yang Y, Wang Z, et al. The risk predictive values of UKPBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210[J]. Aliment Pharmacol Ther, 2017, 45(5):733-743.
[27] Miyachi K, Hankins RW, Matsushima H, et al. Profile and clinical significance of antinuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study[J]. J Autoimmun, 2003, 20(3):247-254.
[28] Stinton LM, Swain M, Myers RP, et al. Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis[J]. Clin Exp Immunol, 2011, 163(2):147-156.
[29] Hudson ME, Pozdnyakova I, Haines K, et al. Identification of differentially expressed proteins in ovarian cancer using highdensity protein microarrays[J]. Proc Natl Acad Sci U S A, 2007, 104(44):17494-17499.
[30] Hu CJ, Song G, Huang W, et al. Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays[J]. Mol Cell Proteomics, 2012,11(9):669-680.
[31] 中华医学会肝病学分会,中华医学会消化病学分会,中华医 学会感染病学分会. 原发性硬化性胆管炎诊断和治疗专家共 识(2015)[J]. 中华肝脏病杂志,2016,24(1):14-22.
[32] Schulte-Pelkum J, Radice A, Norman GL, et al. Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies[J]. J Immunol Res, 2014, 2014:185416.
[33] Hov JR, Boberg KM, Taraldsrud E, et al. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis[J]. Liver Int, 2017, 37(3):458-465.
[34] Jendrek ST, Gotthardt D, Nitzsche T, et al. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis[J]. Gut, 2017, 66(1):137-144

备注/Memo

备注/Memo:
[基金项目] 国家卫生与计划生育委员会医药科技发展研究中 心课题(28-5-5);国家自然科学基金青年科学基金资助项目 (81400609);北京市医院管理局临床医学发展专项—“扬帆” 计划资助项目(ZYLX201711)
[通信作者] 闫惠平,E-mail: yhp503@126.com
更新日期/Last Update: 2018-03-20